PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Journal of Stroke10.5853/jos.2019.019702019213259-275Non-Vitamin K Antagonist Oral Anticoagulants in Medical Conditions at High Risk of Thromboembolism beyond Atrial FibrillationKeun-Sik Honghttp://j-stroke.org/upload/pdf/jos-2019-01970.pdf, http://j-stroke.org/journal/view.php?doi=10.5853/jos.2019.01970, http://j-stroke.org/upload/pdf/jos-2019-01970.pdf
European Heart Journal10.1093/eurheartj/ehab724.0552202142Supplement_1Stroke prevention with non-vitamin K antagonist oral anticoagulants in high risk elderly atrial fibrillation patients at increased bleeding riskT Chao, G.Y.H Lip, S.A Chenhttps://academic.oup.com/eurheartj/article-pdf/42/Supplement_1/ehab724.0552/41057146/ehab724.0552.pdf, https://academic.oup.com/eurheartj/article-pdf/42/Supplement_1/ehab724.0552/41057146/ehab724.0552.pdf
10.21203/rs.3.rs-500778/v12021Risk of Major Bleeding and Thromboembolism in Asian Atrial Fibrillation Patients Using Non-vitamin K Oral Anticoagulants Versus WarfarinYa-Ling Huang, Ching-Yao Chen, Ching-Chi Chuhttps://www.researchsquare.com/article/rs-500778/v1, https://www.researchsquare.com/article/rs-500778/v1.html
Treatment of Non-vitamin K Antagonist Oral Anticoagulants10.1007/978-981-10-1878-7_120161-10Secondary Prevention of Stroke with Atrial Fibrillation by New Oral AnticoagulantsK. Kamiyama, T. Osato, H. Nakamurahttp://link.springer.com/content/pdf/10.1007/978-981-10-1878-7_1
Heart Rhythm10.1016/j.hrthm.2017.01.0252017144606-607Benefits of non–vitamin K antagonist oral anticoagulants in patients with atrial fibrillation go beyond stroke preventionJay A. Montgomery, Gregory F. Michaudhttps://api.elsevier.com/content/article/PII:S1547527117300723?httpAccept=text/plain, https://api.elsevier.com/content/article/PII:S1547527117300723?httpAccept=text/xml
Clinical Interventions in Aging10.2147/cia.s8064120151431Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulantsGreg Flaker, Mohit K. Turagam, Poonam Velagapudihttps://www.dovepress.com/getfile.php?fileID=26885
EP Europace10.1093/europace/euaa162.310202022Supplement_1P471Experience with the use of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation and a high risk of hemorrhagic complicationsE Emelina, G Gendlin, I Nikitinhttp://academic.oup.com/europace/article-pdf/22/Supplement_1/euaa162.310/33547656/euaa162.310.pdf, http://academic.oup.com/europace/article-pdf/22/Supplement_1/euaa162.310/33547656/euaa162.310.pdf
European Heart Journal10.1093/eurheartj/ehz005201940463754-3756Non-vitamin K antagonist oral anticoagulants beyond atrial fibrillation: what did we learn from COMPASS and COMMANDER-HF?Ahsan A Khan, Gregory Y H Liphttp://academic.oup.com/eurheartj/article-pdf/40/46/3754/31247562/ehz005.pdf, http://academic.oup.com/eurheartj/article-pdf/40/46/3754/31247562/ehz005.pdf
Thrombosis Research10.1016/j.thromres.2016.10.0062017150123-130Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation at high risk of bleeding and normal kidney functionInmaculada Hernandez, Kenneth J. Smith, Yuting Zhanghttps://api.elsevier.com/content/article/PII:S0049384816305783?httpAccept=text/plain, https://api.elsevier.com/content/article/PII:S0049384816305783?httpAccept=text/xml
European Heart Journal Supplements10.1093/eurheartj/suaa102202022Supplement_II32-I37Non-vitamin K antagonist oral anticoagulants therapy for atrial fibrillation patients undergoing electrophysiologic proceduresJan Steffelhttp://academic.oup.com/eurheartjsupp/article-pdf/22/Supplement_I/I32/33884914/suaa102.pdf, http://academic.oup.com/eurheartjsupp/article-pdf/22/Supplement_I/I32/33884914/suaa102.pdf